Proof of Principle Study to Evaluate the Safety, PK, Viral Shedding and Efficacy of Pentarlandir™ UPPTA for Patients With Early COVID-19

Name: Proof of Principle Study to Evaluate the Safety, PK, Viral Shedding and Efficacy of Pentarlandir™ UPPTA for Patients With Early COVID-19
Published: 2021
License: Public Domain

SyneuRx International (Taiwan) Corp · 2021

ClinicalTrials.gov · Datasets · License: Public Domain · 2021

Open Source ↗

coronavirus disease 2019, covid-19, pentarlandir™ uppta, uppta, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Proof of Principle Study to Evaluate the Safety, PK, Viral Shedding and Efficacy of Pentarlandir™ UPPTA for Patients With Early COVID-19

Related documents